Forecast: Import of Alkaloids in Dosage Forms to China

The import of alkaloids in dosage forms to China is expected to see consistent growth from 2024 to 2028, with forecasted values rising from USD 522.24 million in 2024 to USD 607.16 million by 2028. In 2023, the import value stood unchanged as this data starts from 2024. Over this period, there is an evident positive trend in the compound annual growth rate.

The year-on-year growth indicates a steady increase between 2024 and 2028, reflecting a resilient demand for imported alkaloids. However, the actual data gap for 2023 indicates an assumption of continued growth from previous years.

Looking forward, key trends to watch include:

• The impact of any regulatory changes in China's pharmaceutical sector.
• Potential shifts in global trade policies that could influence import dynamics.
• Technological advancements in pharmaceutical manufacturing that may affect both demand and domestic production capabilities.